Literature DB >> 15579983

Sudden visual loss after removal of silicone oil.

Richard S B Newsom1, Robert Johnston, Paul M Sullivan, G Bill Aylward, Graham E Holder, Zdenek J Gregor.   

Abstract

PURPOSE: Removal of silicone oil after vitreoretinal surgery reduces potential complications of glaucoma and cataract and improves visual function in 30% of patients. We report the clinical findings of a series of patients who experienced unexpected and permanent visual loss after removal of silicone oil.
METHODS: Seven patients with visual loss after removal of silicon oil were investigated with best-corrected Snellen visual acuity (BCVA) assessment, fundus biomicroscopy, fluorescein angiography, optical coherence tomography, and electrophysiologic examination.
RESULTS: Six men and one woman (average age, 42.8 years.) presented with profound BCVA loss, averaging 4.7 Snellen lines (SD 1.4), after silicon oil removal. No other complications associated with oil removal were noted. The retina remained attached in all cases, no patient developed cystoid macular edema or epiretinal membrane, and optical coherence tomographic and fluorescein angiographic findings remained normal. Electrodiagnostic testing showed a range of abnormalities, with the majority of patients showing severe macular dysfunction.
CONCLUSIONS: We describe a new phenomenon of unexpected visual loss after oil removal in patients with good visual potential. The pathogenesis remains obscure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579983     DOI: 10.1097/00006982-200412000-00005

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  24 in total

1.  Visual loss following silicone oil removal.

Authors:  R S B Newsom; R Johnston; P Sullivan; B Aylward; G Holder; Z Gregor
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

2.  Visual loss may be due to silicone oil tamponade effect rather than silicone oil removal.

Authors:  P K Rani; R Raman; P Bhende; T Sharma
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

3.  Vision loss under silicone oil tamponade.

Authors:  Jan Tode; Konstantine Purtskhvanidze; Till Oppermann; Jost Hillenkamp; Felix Treumer; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-08       Impact factor: 3.117

4.  Central scotoma associated with intraocular silicone oil tamponade develops before oil removal.

Authors:  E N Herbert; M Habib; D Steel; T H Williamson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-27       Impact factor: 3.117

5.  Multifocal electroretinogram in eyes with intravitreal silicone oil and changes following silicone oil removal.

Authors:  Devesh Kumawat; Pranita Sahay; Karthikeyan Mahalingam; S J Vikas; Sagnik Sen; Mousumi Banerjee; Pradeep Venkatesh
Journal:  Doc Ophthalmol       Date:  2019-07-20       Impact factor: 2.379

6.  Immunopathology of intraocular silicone oil: enucleated eyes.

Authors:  Louisa Wickham; Riaz H Asaria; Robert Alexander; Phil Luthert; David G Charteris
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

7.  Silicone oil versus gas tamponade for giant retinal tear-associated fovea-sparing retinal detachment: a comparison of outcome.

Authors:  P J Banerjee; A Chandra; P Petrou; D G Charteris
Journal:  Eye (Lond)       Date:  2017-08-11       Impact factor: 3.775

8.  Vision loss associated with the use and removal of intraocular silicone oil.

Authors:  Patrick D Williams; Christopher G Fuller; Ingrid U Scott; Dwain G Fuller; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2008-12

9.  The incidence of unexplained visual loss following removal of silicone oil.

Authors:  R Moya; A Chandra; P J Banerjee; D Tsouris; N Ahmad; D G Charteris
Journal:  Eye (Lond)       Date:  2015-08-07       Impact factor: 3.775

10.  Foveal light exposure is increased at the time of removal of silicone oil with the potential for phototoxicity.

Authors:  Mahmut Dogramaci; Katie Williams; Ed Lee; Tom H Williamson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.